Applied Therapeutics Inc.(APLT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

APLT Applied Therapeutics Inc.

Trading 01-21 15:13:09 EST

0.1011

+0.0011

+1.10%

High0.1053	Low0.1000	Vol4.23M
Open0.1049	D1 Closing0.1000	Amplitude5.30%
Mkt Cap14.59M	Tradable Cap12.15M	Total Shares144.30M
T/O430.52K	T/O Rate3.51%	Tradable Shares120.21M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"APLT","market":"US","secType":"STK","nameCN":"Applied Therapeutics Inc.","latestPrice":0.1011,"timestamp":1769026371755,"preClose":0.1,"halted":0,"volume":4225485,"delay":0,"changeRate":0.010999999999999899,"floatShares":120214006,"shares":144300674,"eps":-0.1236,"marketStatus":"Trading","change":0.0011,"latestTime":"01-21 15:13:09 EST","open":0.1049,"high":0.1053,"low":0.1,"amount":430516.52241741004,"amplitude":0.053,"askPrice":0.1014,"askSize":600,"bidPrice":0.101,"bidSize":601,"shortable":3,"etf":0,"ttmEps":-0.1236,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1769029200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1557806400000,"exchange":"NASDAQ","adjPreClose":0.1,"preHourTrading":{"tag":"盘前","latestPrice":0.1003,"preClose":0.1,"latestTime":"09:26 EST","volume":124507,"amount":12577.58134849,"timestamp":1769005574316,"change":0.0003,"changeRate":0.003,"amplitude":0.067},"postHourTrading":{"tag":"盘后","latestPrice":0.1001,"preClose":0.1,"latestTime":"19:59 EST","volume":170268,"amount":17148.802489,"timestamp":1768957177924,"change":0.0001,"changeRate":0.001,"amplitude":0.03},"volumeRatio":0.24671,"impliedVol":0.6054,"impliedVolPercentile":0.1673},"requestUrl":"/m/hq/s/APLT","defaultTab":"news","newsList":[{"id":"2592891401","title":"Applied Therapeutics Director Stacy J. Kanter Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592891401","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592891401?lang=en_us&edition=fundamental","pubTime":"2025-12-19 04:14","pubTimestamp":1766088851,"startTime":"0","endTime":"0","summary":"Stacy J. Kanter, Director at Applied Therapeutics Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Applied Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL4Vbp2s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Applied Therapeutics Director Stacy J. Kanter Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","APLT","LU0889565916.HKD","LU0109394709.USD","BK4139"],"gpt_icon":0},{"id":"2591688048","title":"BUZZ-U.S. STOCKS ON THE MOVE-EastGroup, Boeing, Exxon Mobil","url":"https://stock-news.laohu8.com/highlight/detail?id=2591688048","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591688048?lang=en_us&edition=fundamental","pubTime":"2025-12-13 00:57","pubTimestamp":1765558630,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-EastGroup,Boeing, Exxon Mobil Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: htt","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL6N3XI0U8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GE","NVIW.SI","NVDU","NVDS","NVDD","ARB.UK","RENT","THH","NVDS.UK","SNDL","APLT","RIVN","NX","XOM","QH","ZWS","MITK","HL","CDE","BA","FRMI","PUMP","YOU","SNVD.UK","BMI","NEM","NVD2.UK","SCVL","EGP","GD","JOUT","NVDX","R","NVD","WTS","NVDY","CMG","SEI","TLRY","VVPR","RCUS","CTRA","NVD3.UK"],"gpt_icon":1},{"id":"2590507553","title":"BUZZ-U.S. STOCKS ON THE MOVE-ProPetro, Nvidia, Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2590507553","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590507553?lang=en_us&edition=fundamental","pubTime":"2025-12-12 23:01","pubTimestamp":1765551667,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-ProPetro, Nvidia, CitigroupEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL6N3XI0LX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JOUT","NVDD","SCVL","NVDS.UK","CTRA","LU0312595415.SGD","NVIW.SI","SNVD.UK","IE00B4YYXB79.USD","NVD","IE00BVYPNV92.GBP","MITK","LU0069063385.USD","PUMP","SG9999018865.SGD","RCUS","LU1506573853.SGD","CDE","NVDY","LU1084165304.USD","3NVD.UK","XOM","LU2089283258.USD","LU1720051108.HKD","NVDU","LU1582986359.USD","ZWS","LU2498475776.HKD","WTS","NEM","LU1670627923.USD","TLRY","IE00BMPRXR70.SGD","NVDX","2NVD.UK","SNDL","APLT","NX","IE00BMCWC346.EUR","BMI","NVDS","NVDA","HL","C","NVD3.UK","NVD2.UK"],"gpt_icon":1},{"id":"2590950294","title":"Applied Therapeutics Shares Tumble 48.2% to an All-Time Low After Cycle Therapeutics to Buy Co at $0.088 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2590950294","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590950294?lang=en_us&edition=fundamental","pubTime":"2025-12-12 22:35","pubTimestamp":1765550115,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4N3XI11H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","APLT","LU0109394709.USD","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"2590250650","title":"BUZZ-U.S. STOCKS ON THE MOVE-Lululemon, Gold miners, Silver miners","url":"https://stock-news.laohu8.com/highlight/detail?id=2590250650","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590250650?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:32","pubTimestamp":1765542738,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Lululemon, Gold miners, Silver minersEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL6N3XI0NM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1935042991.SGD","LU2168564065.EUR","IE0009356076.USD","LU1935042488.USD","LU2065169927.USD","LU1804176565.USD","LU1732799900.SGD","BK4512","SNDL","LU0077335932.USD","APLT","LU0203202063.USD","LU1223082519.USD","NX","XOM","IE0002270589.USD","MITK","LU2168564495.EUR","ZWS","LU0689626769.HKD","BK4543","LU2462611646.USD","HL","LU1670711040.USD","LU2168563687.JPY","SG9999018857.SGD","CDE","IE00BKPKM429.USD","LU0203201768.USD","BMI","LU0122376428.USD","NEM","LU1699723380.USD","LU0889565833.HKD","SCVL","LU0106261372.USD","LULU","JOUT","WTS","BK4017","LU2168564149.EUR","TLRY","LU2168564222.USD","BK4210","LU2106854487.HKD","LU1917777945.USD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2590708985","title":"BUZZ-Applied Therapeutics plunges after UK's Cycle Group to buy co","url":"https://stock-news.laohu8.com/highlight/detail?id=2590708985","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590708985?lang=en_us&edition=fundamental","pubTime":"2025-12-12 18:22","pubTimestamp":1765534952,"startTime":"0","endTime":"0","summary":"BUZZ-Applied Therapeutics plunges after UK's Cycle Group to buy co** Rare diseases drug developer Applied Therapeutics' APLT.O shares slump 35.5% to $0.14 premarket** Co said on Thursday UK-based Cycl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL6N3XI0JB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0889565916.HKD","LU0109394709.USD","APLT","LU0320765992.SGD"],"gpt_icon":0},{"id":"2590743125","title":"Applied Therapeutics Shares Slump 35% Premarket After Cycle Therapeutics to Buy Co at $0.088 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2590743125","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590743125?lang=en_us&edition=fundamental","pubTime":"2025-12-12 17:04","pubTimestamp":1765530240,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4N3XI0L3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APLT","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2590254407","title":"Cycle Pharmaceuticals to Acquire Applied Therapeutics for $0.088 Per Share Plus CVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2590254407","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590254407?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:25","pubTimestamp":1765491915,"startTime":"0","endTime":"0","summary":"Cycle Group Holdings Limited has reached a definitive agreement to acquire Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on treatments for rare diseases. Under the agreement, Cycle will launch a tender offer to purchase all outstanding shares of Applied Therapeutics for $0.088 per share in cash at closing, along with one non-transferrable contingent value right  per share, which may provide additional payments based on future milestones. The boards of both companies have approved the transaction, which is expected to close in the first quarter of 2026, subject to customary closing conditions. Applied Therapeutics' lead drug candidate, govorestat, is being developed for several rare central nervous system metabolic diseases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL6Xg7r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4588","LU0889565916.HKD","BK4139","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","LU2210149790.SGD","LU0320765992.SGD","LU2095319765.USD","APLT","SG9999014039.USD","SG9999014005.SGD","SG9999014013.SGD","IE00BKPKM429.USD","SG9999014021.USD","LU2210150020.SGD","BK4585","BK4112","NDAQ","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2590544701","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 05:21 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2590544701","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590544701?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:21","pubTimestamp":1765491660,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 05:21 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nAQN2LD9DR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0320765992.SGD","LU0109394709.USD","APLT","LU0889565916.HKD"],"gpt_icon":0},{"id":"2584136954","title":"Applied Therapeutics Cuts Workforce and Explores Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2584136954","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584136954?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:00","pubTimestamp":1763640051,"startTime":"0","endTime":"0","summary":"Applied Therapeutics Inc., a clinical-stage biopharmaceutical company, has announced that its Board of Directors has initiated a process to explore strategic alternatives, which may include mergers, acquisitions, partnerships, or other transactions aimed at maximizing shareholder value. As part of this process and to preserve its cash runway, the company is reducing its workforce by approximately 46% and implementing additional cost-containment measures. The review of strategic options is ongoing, and there is no set timetable for completion or assurance that it will result in any specific outcome.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Applied Therapeutics Inc. published the original content used to generate this news brief vi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL4xHlNQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0109394709.USD","BK4139","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","APLT","BK4588","BK4585","LU0314104364.USD","LU2210150020.SGD","LU0889565916.HKD","NDAQ","IE00BKPKM429.USD","BK4112","LU2210149790.SGD","LU2095319765.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2584136603","title":"Applied Therapeutics Inc - to Reduce Workforce by 46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584136603","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584136603?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:00","pubTimestamp":1763640022,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WW0QP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU0889565916.HKD","BK4139","LU0109394709.USD","APLT"],"gpt_icon":0},{"id":"2584136199","title":"Applied Therapeutics: Expects to Submit Request for Additional Type C Meeting With FDA to Further Discuss Potential Phase 3 Trial Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2584136199","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584136199?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:00","pubTimestamp":1763640022,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WW0QP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0320765992.SGD","LU0109394709.USD","APLT","LU0889565916.HKD"],"gpt_icon":0},{"id":"2583635754","title":"RBC Capital Remains a Hold on Applied Therapeutics (APLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583635754","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583635754?lang=en_us&edition=fundamental","pubTime":"2025-11-15 09:49","pubTimestamp":1763171354,"startTime":"0","endTime":"0","summary":"In a report released on November 13, Brian Abrahams from RBC Capital maintained a Hold rating on Applied Therapeutics, with a price target of $1.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-hold-on-applied-therapeutics-aplt-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-hold-on-applied-therapeutics-aplt-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","BK4139","LU0029864427.USD","LU0708994859.HKD","LU0320765992.SGD","LU0310800379.SGD","APLT","LU0889565916.HKD","LU1267930573.SGD","LU0109394709.USD","BK4207"],"gpt_icon":0},{"id":"2583721633","title":"Are Applied Therapeutics' (APLT) Narrowing Losses a Turning Point for Its Strategic Vision?","url":"https://stock-news.laohu8.com/highlight/detail?id=2583721633","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583721633?lang=en_us&edition=fundamental","pubTime":"2025-11-15 07:30","pubTimestamp":1763163018,"startTime":"0","endTime":"0","summary":"Applied Therapeutics released its third quarter 2025 earnings, reporting revenue of US$1 million and a net loss of US$18.99 million, both improved from the previous year; the company also announced Executive Chairman John Johnson's resignation for personal reasons.\nThe sizable reduction in net losses and increased revenue, alongside leadership changes unconnected to business issues, may shape future corporate priorities.\nWe'll explore how Applied Therapeutics' narrowing quarterly losses...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aplt/applied-therapeutics/news/are-applied-therapeutics-aplt-narrowing-losses-a-turning-poi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aplt/applied-therapeutics/news/are-applied-therapeutics-aplt-narrowing-losses-a-turning-poi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0320765992.SGD","BK4075","LU0889565916.HKD","TPB","APLT","BK4139","LU0109394709.USD"],"gpt_icon":0},{"id":"2583254807","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Applied Therapeutics (APLT) and Xilio Therapeutics (XLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583254807","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583254807?lang=en_us&edition=fundamental","pubTime":"2025-11-14 06:50","pubTimestamp":1763074211,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Applied Therapeutics (APLT – Research Report) and Xilio Therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-applied-therapeutics-aplt-and-xilio-therapeutics-xlo-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-applied-therapeutics-aplt-and-xilio-therapeutics-xlo-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","APLT","XLO","BK4139","BK4137","LU0029874061.USD","LU0889565916.HKD","XLV","BK4581","LABU","LU0128526141.USD","HCSG","LU0320765992.SGD","LU0109394709.USD","BK4588","XBI"],"gpt_icon":0},{"id":"2583513588","title":"Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain","url":"https://stock-news.laohu8.com/highlight/detail?id=2583513588","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583513588?lang=en_us&edition=fundamental","pubTime":"2025-11-14 02:05","pubTimestamp":1763057100,"startTime":"0","endTime":"0","summary":"Applied Therapeutics stock falls after FDA feedback prompts another Type C meeting to discuss the Phase 3 plan for its CMT-SORD drug govorestat.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/13/Applied-Therapeutics.jpeg?optimize=medium&dpr=2&auto=webp&width=120","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/13/Applied-Therapeutics.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/11/48843784/applied-therapeutics-tanks-as-fda-path-for-lead-rare-disease-drug-turns-uncertain","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/11/48843784/applied-therapeutics-tanks-as-fda-path-for-lead-rare-disease-drug-turns-uncertain","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["APLT","LU0889565916.HKD","LU0320765992.SGD","LENZ","BK4007","BK4139","LU0109394709.USD","BK4539"],"gpt_icon":0},{"id":"2583621065","title":"Applied Therapeutics Q3 net loss of $19 mln beats expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2583621065","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583621065?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:13","pubTimestamp":1763035992,"startTime":"0","endTime":"0","summary":"Applied Therapeutics Q3 net loss of $19 mln beats expectationsOverviewApplied Therapeutics Q3 net loss of $19 mln beats analyst expectationsCompany's Q3 operating income also beats analyst expectation","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL1N3WP0GI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","BK4139","APLT"],"gpt_icon":0},{"id":"2583621135","title":"Applied Therapeutics Reports Q3 2025 Results and Board Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2583621135","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583621135?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:12","pubTimestamp":1763035923,"startTime":"0","endTime":"0","summary":"Applied Therapeutics Inc. reported its financial results for the third quarter ended September 30, 2025. The company announced cash and cash equivalents of $11.9 million as of September 30, 2025, compared to $79.4 million at December 31, 2024. Applied Therapeutics provided updates on its regulatory strategy for govorestat, including a completed meeting with the FDA regarding a potential NDA submission for the treatment of CMT-SORD and plans to submit a meeting request for further discussion on a potential Phase 3 trial. A meeting with the FDA is also scheduled in the fourth quarter of 2025 to discuss govorestat for Classic Galactosemia. Additionally, new data on govorestat for PMM2-CDG was published and presented at the 2025 ASHG Annual Meeting. The company also announced a leadership transition, with John Johnson stepping down as Executive Chairman and director for personal reasons.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL7HxY1T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","APLT","LU0109394709.USD","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"2583564284","title":"Applied Therapeutics Q3 EPS USD -0.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2583564284","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583564284?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:00","pubTimestamp":1763035204,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLXC7522E:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","LU0320765992.SGD","BK4139","LU0109394709.USD","APLT"],"gpt_icon":0},{"id":"2583562589","title":"Applied Therapeutics Inc -in Nov, John Johnson to Step Down as Executive Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2583562589","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583562589?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:00","pubTimestamp":1763035204,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLXC7522E:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","BK4139","LU0320765992.SGD","LU0889565916.HKD","APLT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.appliedtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.2},{"period":"3month","weight":-0.9281},{"period":"6month","weight":-0.8035},{"period":"1year","weight":-0.8469},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0044},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.068},{"period":"1year","weight":0.1339},{"period":"ytd","weight":-0.0064}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target central nervous system rare disease and diabetic complications in the United States. Its lead product candidate is AT-007 that has completed phase III for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":0.042681},{"month":2,"riseRate":0.333333,"avgChangeRate":0.081838},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.084606},{"month":4,"riseRate":0.333333,"avgChangeRate":0.099604},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.061145},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.095669},{"month":7,"riseRate":0.714286,"avgChangeRate":0.127586},{"month":8,"riseRate":0.571429,"avgChangeRate":0.03043},{"month":9,"riseRate":0.714286,"avgChangeRate":0.150737},{"month":10,"riseRate":0.428571,"avgChangeRate":0.129556},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.13558},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.091855}],"exchange":"NASDAQ","name":"Applied Therapeutics Inc.","nameEN":"Applied Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Applied Therapeutics Inc.(APLT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Applied Therapeutics Inc.(APLT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Applied Therapeutics Inc.,APLT,Applied Therapeutics Inc.股票,Applied Therapeutics Inc.股票老虎,Applied Therapeutics Inc.股票老虎国际,Applied Therapeutics Inc.行情,Applied Therapeutics Inc.股票行情,Applied Therapeutics Inc.股价,Applied Therapeutics Inc.股市,Applied Therapeutics Inc.股票价格,Applied Therapeutics Inc.股票交易,Applied Therapeutics Inc.股票购买,Applied Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Applied Therapeutics Inc.(APLT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Applied Therapeutics Inc.(APLT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction